These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17549794)

  • 1. Broad spectrum identification of SUMO substrates in melanoma cells.
    Ganesan AK; Kho Y; Kim SC; Chen Y; Zhao Y; White MA
    Proteomics; 2007 Jun; 7(13):2216-21. PubMed ID: 17549794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SUMO targets through in vitro expression cloning.
    Gocke CB; Yu H
    Methods Mol Biol; 2009; 497():51-61. PubMed ID: 19107410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation--a new target for therapeutic intervention?
    Yang W; Sheng H; Homi HM; Warner DS; Paschen W
    J Neurochem; 2008 Aug; 106(3):989-99. PubMed ID: 18410505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
    Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
    Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.
    Cui Y; Guadagno TM
    Oncogene; 2008 May; 27(22):3122-33. PubMed ID: 18071315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
    Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S
    Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
    Gao K; Dai DL; Martinka M; Li G
    Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.
    Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP
    Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
    Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL
    Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of SUMO in pancreatic beta-cells.
    Ehninger A; Mziaut H; Solimena M
    Horm Metab Res; 2007 Sep; 39(9):658-64. PubMed ID: 17846973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
    Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
    Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation of Drosophila transcription factor STAT92E.
    Grönholm J; Ungureanu D; Vanhatupa S; Rämet M; Silvennoinen O
    J Innate Immun; 2010; 2(6):618-24. PubMed ID: 20616536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins.
    Zhao Y; Kwon SW; Anselmo A; Kaur K; White MA
    J Biol Chem; 2004 May; 279(20):20999-1002. PubMed ID: 15016812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.